Lyra Therapeutics Inc (LYRA) Stock Price & News

All values in USD	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	183.00K	183.00K	25.00K	7.00K
Cost of goods sold	4.88M	5.11M	4.05M	-13.03M
Cost of revenue	4.88M	5.11M	4.05M	-13.03M
Research and development expenses	-	-	-	17.40M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.26M	3.50M	2.24M	2.54M
Operating expense	3.26M	3.50M	2.24M	19.94M
Total operating expenses	8.14M	8.61M	6.28M	6.92M
Operating income	-7.96M	-8.43M	-6.26M	-6.91M
Other non operating income	-	-	-	-
EBT including unusual items	-8.54M	-7.44M	-5.98M	-6.95M
EBT excluding unusual items	-7.66M	-8.02M	-6.00M	-6.74M
Income tax expense	4.00K	2.00K	3.00K	2.00K
Effective tax rate	-0.05%	-0.03%	-0.05%	-0.03%
Other operating expenses	-	-	-	-
Net income	-8.55M	-7.44M	-5.98M	-6.95M
Net profit margin	-4,670.49%	-4,063.93%	-23,936.00%	-99,300.00%
Earnings per share	-	-5.22	-3.40	-
Interest and investment income	298.00K	410.00K	256.00K	169.00K
Interest expense	-	-	-	-
Net interest expenses	298.00K	410.00K	256.00K	169.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	-7.83M	-8.30M	-6.15M	-6.81M
Gain or loss from assets sale	-	-8.00K	-	-

Finance